112 related articles for article (PubMed ID: 21346352)
41. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia.
Le Hello S; Falcot V; Lacassin F; Baumann F; Nordmann P; Naas T
Clin Microbiol Infect; 2008 Oct; 14(10):977-81. PubMed ID: 18828857
[TBL] [Abstract][Full Text] [Related]
42. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A
Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
[TBL] [Abstract][Full Text] [Related]
43. An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis.
Jamulitrat S; Thongpiyapoom S; Suwalak N
J Med Assoc Thai; 2007 Oct; 90(10):2181-91. PubMed ID: 18041440
[TBL] [Abstract][Full Text] [Related]
44. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
[TBL] [Abstract][Full Text] [Related]
45. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem.
Pachón-Ibáñez ME; Jiménez-Mejías ME; Pichardo C; Llanos AC; Pachón J
Antimicrob Agents Chemother; 2004 Nov; 48(11):4479-81. PubMed ID: 15504889
[TBL] [Abstract][Full Text] [Related]
46. Emergence of an extreme-drug-resistant (XDR) Acinetobacter baumannii carrying blaOXA-23 in a patient with acute necrohaemorrhagic pancreatitis.
Grosso F; Quinteira S; Peixe L
J Hosp Infect; 2010 May; 75(1):82-3. PubMed ID: 20303617
[No Abstract] [Full Text] [Related]
47. [Characterization of the resistance mechanism to beta-lactams in Acinetobacter baumannii strains isolated in the university hospital Sahloul in Tunisia (2005)].
Mansour W; Bouallegue O; Dahmen S; Boujaafar N
Pathol Biol (Paris); 2008 May; 56(3):116-20. PubMed ID: 18178020
[TBL] [Abstract][Full Text] [Related]
48. Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance.
Limansky AS; Mussi MA; Viale AM
J Clin Microbiol; 2002 Dec; 40(12):4776-8. PubMed ID: 12454194
[TBL] [Abstract][Full Text] [Related]
49. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
[TBL] [Abstract][Full Text] [Related]
50. Comparative Phosphoproteomics Reveals the Role of AmpC β-lactamase Phosphorylation in the Clinical Imipenem-resistant Strain Acinetobacter baumannii SK17.
Lai JH; Yang JT; Chern J; Chen TL; Wu WL; Liao JH; Tsai SF; Liang SY; Chou CC; Wu SH
Mol Cell Proteomics; 2016 Jan; 15(1):12-25. PubMed ID: 26499836
[TBL] [Abstract][Full Text] [Related]
51. Outer-membrane proteins pattern and detection of beta-lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil.
Costa SF; Woodcock J; Gill M; Wise R; Barone AA; Caiaffa H; Levin AS
Int J Antimicrob Agents; 2000 Jan; 13(3):175-82. PubMed ID: 10724021
[TBL] [Abstract][Full Text] [Related]
52. Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein.
Clark RB
J Antimicrob Chemother; 1996 Aug; 38(2):245-51. PubMed ID: 8877538
[TBL] [Abstract][Full Text] [Related]
53. Development of a high-throughput cloning strategy for characterization of Acinetobacter baumannii drug transporter proteins.
Eijkelkamp BA; Hassan KA; Paulsen IT; Brown MH
J Mol Microbiol Biotechnol; 2011; 20(4):211-9. PubMed ID: 21778766
[TBL] [Abstract][Full Text] [Related]
54. [Lower respiratory tract of pneumoconiosis on fosfomycin antibacterial activity in vitro of fosfomycin to infected in coal worker pneumoconiosis in vitro antibacterial activity].
Liu PY; Gu DQ; Zhang KH
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Jul; 29(7):547-8. PubMed ID: 22214170
[No Abstract] [Full Text] [Related]
55. Efflux pump overexpression in multiple-antibiotic-resistant mutants of Bacteroides fragilis.
Pumbwe L; Glass D; Wexler HM
Antimicrob Agents Chemother; 2006 Sep; 50(9):3150-3. PubMed ID: 16940115
[TBL] [Abstract][Full Text] [Related]
56. Effect of applying the new CLSI imipenem susceptibility breakpoints for Enterobacteriaceae in Hong Kong.
Ho PL; Lai EL; Chow KH; Cheng VC
J Antimicrob Chemother; 2011 Nov; 66(11):2671-3. PubMed ID: 21816765
[No Abstract] [Full Text] [Related]
57. AbuO, a TolC-like outer membrane protein of Acinetobacter baumannii, is involved in antimicrobial and oxidative stress resistance.
Srinivasan VB; Vaidyanathan V; Rajamohan G
Antimicrob Agents Chemother; 2015 Feb; 59(2):1236-45. PubMed ID: 25512405
[TBL] [Abstract][Full Text] [Related]
58. Identification of carbonylated proteins in a bactericidal process induced by curcumin with blue light irradiation on imipenem-resistant Acinetobacter baumannii.
Chang KC; Cheng YY; Lai MJ; Hu A
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8548. PubMed ID: 31397940
[TBL] [Abstract][Full Text] [Related]
59. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system.
Marchand I; Damier-Piolle L; Courvalin P; Lambert T
Antimicrob Agents Chemother; 2004 Sep; 48(9):3298-304. PubMed ID: 15328088
[TBL] [Abstract][Full Text] [Related]
60. In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii.
Verma P; Tiwari M; Tiwari V
J Biomol Struct Dyn; 2018 Apr; 36(5):1182-1194. PubMed ID: 28393677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
